Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Rosoxacin | hsa00030 | Pentose phosphate pathway | 1.03E-03 | 4 | P06744, P60891, P52209, P37837 | GPI, PRPS1, PGD, TALDO1 | More | | Rosoxacin | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Rosoxacin | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Rosoxacin | hsa00190 | Oxidative phosphorylation | 3.56E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Rosoxacin | hsa00220 | Arginine biosynthesis | 2.25E-05 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Rosoxacin | hsa00230 | Purine metabolism | 1.73E-03 | 4 | P31350, P21589, P20839, Q02153 | RRM2, NT5E, IMPDH1, GUCY1B3 | More | | Rosoxacin | hsa00240 | Pyrimidine metabolism | 6.80E-07 | 5 | P31350, P21589, P32320, P04183, P04818 | RRM2, NT5E, CDA, TK1, TYMS | More | | Rosoxacin | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Rosoxacin | hsa00310 | Lysine degradation | 4.57E-02 | 2 | Q96KQ7, Q02809 | EHMT2, PLOD1 | More | | Rosoxacin | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | | Rosoxacin | hsa00500 | Starch and sucrose metabolism | 1.91E-04 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Rosoxacin | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Rosoxacin | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Rosoxacin | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 2.03E-02 | 1 | P35557 | GCK | More | | Rosoxacin | hsa00562 | Inositol phosphate metabolism | 2.00E-02 | 4 | P27987, P19174, P42338, Q02252 | ITPKB, PLCG1, PIK3CB, ALDH6A1 | More | | Rosoxacin | hsa00565 | Ether lipid metabolism | 3.00E-03 | 1 | Q8N661 | TMEM86B | More | | Rosoxacin | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Rosoxacin | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Rosoxacin | hsa00600 | Sphingolipid metabolism | 2.68E-02 | 2 | P07602, Q13510 | PSAP, ASAH1 | More | | Rosoxacin | hsa00630 | Glyoxylate and dicarboxylate metabolism | 6.40E-07 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Rosoxacin | hsa00640 | Propanoate metabolism | 3.83E-02 | 2 | Q02252, Q9P2R7 | ALDH6A1, SUCLA2 | More | | Rosoxacin | hsa00670 | One carbon pool by folate | 3.15E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | Rosoxacin | hsa00730 | Thiamine metabolism | 1.38E-05 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Rosoxacin | hsa00740 | Riboflavin metabolism | 4.03E-02 | 1 | P24666 | ACP1 | More | | Rosoxacin | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Rosoxacin | hsa00790 | Folate biosynthesis | 1.04E-02 | 3 | Q92820, P05186, P42330 | GGH, ALPL, AKR1C3 | More | | Rosoxacin | hsa00830 | Retinol metabolism | 4.55E-02 | 1 | P00325 | ADH1B | More | | Rosoxacin | hsa00860 | Porphyrin and chlorophyll metabolism | 3.15E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Rosoxacin | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Rosoxacin | hsa00920 | Sulfur metabolism | 4.01E-04 | 1 | Q16762 | TST | More | | Rosoxacin | hsa00970 | Aminoacyl-tRNA biosynthesis | 6.41E-05 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Rosoxacin | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-05 | 4 | Q16772, P78417, P09211, P11712 | GSTA3, GSTO1, GSTP1, CYP2C9 | More | | Rosoxacin | hsa00982 | Drug metabolism - cytochrome P450 | 1.77E-04 | 4 | P11712, Q16772, P09211, P78417 | CYP2C9, GSTA3, GSTP1, GSTO1 | More | | Rosoxacin | hsa00983 | Drug metabolism - other enzymes | 5.40E-07 | 6 | P04183, P32320, P31350, P05164, Q16772, P09211 | TK1, CDA, RRM2, MPO, GSTA3, GSTP1 | More | | Rosoxacin | hsa01040 | Biosynthesis of unsaturated fatty acids | 4.28E-02 | 1 | P22307 | SCP2 | More | | Rosoxacin | hsa01100 | Metabolic pathways | 3.55E-03 | 34 | Q9NR34, P35790, P05089, Q16772, P09211, Q9UJ14, P30041, P32320, P22748, P40926, P55809, P06280, Q16875, O43286, O43451, Q7KZN9, P05186, P24666, P15121, Q9HCC0, P33121, Q9UHK6, Q86VZ5, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q9BQB6 | MAN1C1, CHKA, ARG1, GSTA3, GSTP1, GGTL3, PRDX6, CDA, CA4, MDH2, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, COX15, ALPL, ACP1, AKR1B1, MCCC2, ACSL1, AMACR, SGMS1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, VKORC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P35790 | CHKA | Choline kinase alpha | -0.717 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.793 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P09211 | GSTP1 | Glutathione S-transferase P | 0.712 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | 0.748 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.75 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | 0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q7KZN9 | COX15 | Cytochrome c oxidase assembly protein COX15 homolog | 0.764 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.704 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.736 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9BQB6 | VKORC1 | Vitamin K epoxide reductase complex subunit 1 | 0.731 |
| Rosoxacin | hsa01200 | Carbon metabolism | 7.69E-03 | 3 | P06744, P37837, P40926 | GPI, TALDO1, MDH2 | More | | Rosoxacin | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | | Rosoxacin | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P08069 | IGF1R | More | | Rosoxacin | hsa01523 | Antifolate resistance | 2.19E-07 | 6 | P41439, P41440, Q92820, P04818, P01375, P18054 | FOLR3, SLC19A1, GGH, TYMS, TNF, ALOX12 | More | | Rosoxacin | hsa01524 | Platinum drug resistance | 4.95E-04 | 6 | O15392, Q16772, P09211, P78417, P11388, P52701 | BIRC5, GSTA3, GSTP1, GSTO1, TOP2A, MSH6 | More | | Rosoxacin | hsa02010 | ABC transporters | 2.17E-03 | 1 | Q8IZY2 | ABCA7 | More | | Rosoxacin | hsa03010 | Ribosome | 7.34E-03 | 6 | P62753, P62829, P62888, P61927, P61513, P36578 | RPS6, RPL23, RPL30, RPL37, RPL37A, RPL4 | More | | Rosoxacin | hsa03013 | RNA transport | 1.16E-08 | 24 | P62826, O14980, P52298, Q09161, O14893, P61326, Q15287, Q9UBU9, Q9H307, Q7Z3B4, P35658, P63279, P68104, Q14152, P55884, O15371, O75822, P78345, P20042, Q14240, Q9Y6A5, Q14232, Q06787, P51114 | RAN, XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, RNPS1, NXF1, PNN, NUP54, NUP214, UBE2I, EEF1A1, EIF3A, EIF3B, EIF3D, EIF3J, RPP38, EIF2S2, EIF4A2, TACC3, EIF2B1, FMR1, FXR1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P62826 | RAN | GTP-binding nuclear protein Ran | 0.732 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | O14980 | XPO1 | Exportin-1 | 0.943 | P08246 | ELA2 | Neutrophil elastase | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | -0.852 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.888 | P08246 | ELA2 | Neutrophil elastase | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | -0.732 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.742 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.742 | P08246 | ELA2 | Neutrophil elastase | O14893 | GEMIN2 | Gem-associated protein 2 | -0.785 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.853 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | P61326 | MAGOH | Protein mago nashi homolog | 0.737 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.756 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.723 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.79 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q9H307 | PNN | Pinin | 0.722 | P08246 | ELA2 | Neutrophil elastase | Q7Z3B4 | NUP54 | Nucleoporin p54 | -0.723 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.787 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.774 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.725 | P08246 | ELA2 | Neutrophil elastase | P35658 | NUP214 | Nuclear pore complex protein Nup214 | 0.765 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.781 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.751 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.736 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.739 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P68104 | EEF1A1 | Elongation factor 1-alpha 1 | 0.721 | P08246 | ELA2 | Neutrophil elastase | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | -0.722 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.902 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.734 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.731 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | O15371 | EIF3D | Eukaryotic translation initiation factor 3 subunit D | 0.77 | P08246 | ELA2 | Neutrophil elastase | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | -0.825 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.83 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.837 | P08246 | ELA2 | Neutrophil elastase | P78345 | RPP38 | Ribonuclease P protein subunit p38 | -0.795 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.852 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P20042 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit 2 | 0.733 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.867 | P08246 | ELA2 | Neutrophil elastase | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | 0.849 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.812 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q14232 | EIF2B1 | Translation initiation factor eIF-2B subunit alpha | 0.749 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.772 | Q9UBU7 | DBF4 | Protein DBF4 homolog A | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.854 |
| Rosoxacin | hsa03018 | RNA degradation | 5.00E-02 | 1 | Q9NQT4 | EXOSC5 | More | | Rosoxacin | hsa03020 | RNA polymerase | 4.09E-05 | 4 | P30876, P24928, P62487, Q9Y535 | POLR2B, POLR2A, POLR2G, POLR3H | More | | Rosoxacin | hsa03030 | DNA replication | 5.00E-02 | 1 | P27694 | RPA1 | More | | Rosoxacin | hsa03040 | Spliceosome | 3.61E-13 | 19 | Q14562, O43143, O60508, P17844, P08579, Q15427, P26368, P51991, P38159, P61978, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, DDX5, SNRPB2, SF3B4, U2AF2, HNRPA3, RBMX, HNRPK, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.888 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.803 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.781 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.953 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.869 | P29375 | JARID1A | Lysine-specific demethylase 5A | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.794 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.838 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.827 | P29375 | JARID1A | Lysine-specific demethylase 5A | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.875 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.73 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.788 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.778 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15427 | SF3B4 | Splicing factor 3B subunit 4 | 0.71 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P51991 | HNRPA3 | Heterogeneous nuclear ribonucleoprotein A3 | 0.787 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P38159 | RBMX | RNA-binding motif protein, X chromosome | 0.733 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.827 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.784 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.935 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.866 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.882 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.835 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.862 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.886 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.908 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.732 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.746 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.928 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.709 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.786 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | 0.78 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Rosoxacin | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Rosoxacin | hsa03060 | Protein export | 1.13E-03 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Rosoxacin | hsa03320 | PPAR signaling pathway | 4.55E-02 | 2 | O00767, Q02318 | SCD, CYP27A1 | More | | Rosoxacin | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Rosoxacin | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | | Rosoxacin | hsa04012 | ErbB signaling pathway | 8.75E-06 | 8 | P21860, P16333, P17252, Q13557, P19174, O14944, P42338, P01106 | ERBB3, NCK1, PRKCA, CAMK2D, PLCG1, EREG, PIK3CB, MYC | More | | Rosoxacin | hsa04014 | Ras signaling pathway | 1.30E-08 | 16 | P42338, P20827, Q9NRA1, P49767, P08069, Q13009, P17252, P14921, Q7LDG7, Q15283, P61586, P0DP23, P62873, P63218, P50151, P19174 | PIK3CB, EFNA1, PDGFC, VEGFC, IGF1R, TIAM1, PRKCA, ETS1, RASGRP2, RASA2, RHOA, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P20827 | EFNA1 | Ephrin-A1 | -0.872 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P20827 | EFNA1 | Ephrin-A1 | -0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P20827 | EFNA1 | Ephrin-A1 | 0.715 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q9NRA1 | PDGFC | Platelet-derived growth factor C | -0.702 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.871 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P49767 | VEGFC | Vascular endothelial growth factor C | -0.778 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P08069 | IGF1R | Insulin-like growth factor 1 receptor | P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.792 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.706 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14921 | ETS1 | Protein C-ets-1 | 0.731 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P61586 | RHOA | Transforming protein RhoA | Q15283 | RASA2 | Ras GTPase-activating protein 2 | -0.836 | P61586 | RHOA | Transforming protein RhoA | P61586 | RHOA | Transforming protein RhoA | 1 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P0DP23 | CALM1 | Calmodulin-1 | 0.826 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | P61586 | RHOA | Transforming protein RhoA | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.7 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 |
| Rosoxacin | hsa04015 | Rap1 signaling pathway | 4.08E-06 | 12 | P20827, Q9NRA1, P49767, P08069, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P0DP23, P17252, P19174 | EFNA1, PDGFC, VEGFC, IGF1R, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, CALM1, PRKCA, PLCG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P20827 | EFNA1 | Ephrin-A1 | -0.872 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P20827 | EFNA1 | Ephrin-A1 | -0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P20827 | EFNA1 | Ephrin-A1 | 0.715 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q9NRA1 | PDGFC | Platelet-derived growth factor C | -0.702 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.871 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P49767 | VEGFC | Vascular endothelial growth factor C | -0.778 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P08069 | IGF1R | Insulin-like growth factor 1 receptor | P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q96FS4 | SIPA1 | Signal-induced proliferation-associated protein 1 | 0.728 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P11215 | ITGAM | Integrin alpha-M | -0.768 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P11215 | ITGAM | Integrin alpha-M | -0.877 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11215 | ITGAM | Integrin alpha-M | 0.817 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.792 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.706 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P0DP23 | CALM1 | Calmodulin-1 | 0.826 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 |
| Rosoxacin | hsa04020 | Calcium signaling pathway | 2.42E-07 | 17 | P27987, Q96DU7, Q08828, P21796, P45880, Q13557, P17252, P21860, P30679, O15399, P19174, P0DP23, P05141, P51828, P23634, Q9NRA1, P49767 | ITPKB, ITPKC, ADCY1, VDAC1, VDAC2, CAMK2D, PRKCA, ERBB3, GNA15, GRIN2D, PLCG1, CALM1, SLC25A5, ADCY7, ATP2B4, PDGFC, VEGFC | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P27987 | ITPKB | Inositol-trisphosphate 3-kinase B | 0.861 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P27987 | ITPKB | Inositol-trisphosphate 3-kinase B | 0.891 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q96DU7 | ITPKC | Inositol-trisphosphate 3-kinase C | -0.802 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.796 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 0.72 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 0.709 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.708 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.707 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | -0.772 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P30679 | GNA15 | Guanine nucleotide-binding protein subunit alpha-15 | -0.758 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | -0.734 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P0DP23 | CALM1 | Calmodulin-1 | 0.826 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.779 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.704 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.726 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P23634 | ATP2B4 | Plasma membrane calcium-transporting ATPase 4 | 0.796 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P23634 | ATP2B4 | Plasma membrane calcium-transporting ATPase 4 | 0.73 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q9NRA1 | PDGFC | Platelet-derived growth factor C | -0.702 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.871 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P49767 | VEGFC | Vascular endothelial growth factor C | -0.778 |
| Rosoxacin | hsa04022 | cGMP-PKG signaling pathway | 6.39E-04 | 9 | Q99941, P18848, P23634, P31751, Q08828, P51828, P05141, P45880, P0DP23 | CREBL1, ATF4, ATP2B4, AKT2, ADCY1, ADCY7, SLC25A5, VDAC2, CALM1 | More | | Rosoxacin | hsa04024 | cAMP signaling pathway | 6.55E-04 | 9 | Q08828, P51828, P42338, P31751, P0DP23, Q13370, O15399, P25963, Q13009 | ADCY1, ADCY7, PIK3CB, AKT2, CALM1, PDE3B, GRIN2D, NFKBIA, TIAM1 | More | | Rosoxacin | hsa04060 | Cytokine-cytokine receptor interaction | 5.39E-03 | 10 | P27930, P08476, Q13651, Q9HBE5, Q9UBD3, P47992, P01375, P09341, P18510, Q93038 | IL1R2, INHBA, IL10RA, IL21R, XCL2, XCL1, TNF, CXCL1, IL1RN, TNFRSF25 | More | | Rosoxacin | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.51E-08 | 13 | Q8NHW4, P09341, P19875, P25024, P02775, P25025, P61073, P47992, Q9UBD3, Q13651, P14784, P09603, P01375 | CCL4L2, CXCL1, CXCL2, CXCR1, PPBP, CXCR2, CXCR4, XCL1, XCL2, IL10RA, IL2RB, CSF1, TNF | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.727 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.727 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | O00767 | SCD | Stearoyl-CoA desaturase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.702 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.859 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.927 | P08311 | CTSG | Cathepsin G | P09341 | CXCL1 | Growth-regulated alpha protein | 0.877 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | 0.901 | Q13547 | HDAC1 | Histone deacetylase 1 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.803 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.772 | O00767 | SCD | Stearoyl-CoA desaturase | P02775 | PPBP | Platelet basic protein | -0.773 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.917 | Q13547 | HDAC1 | Histone deacetylase 1 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | -0.719 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | -0.754 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.774 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P47992 | XCL1 | Lymphotactin | -0.797 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P47992 | XCL1 | Lymphotactin | 0.83 | P08311 | CTSG | Cathepsin G | P47992 | XCL1 | Lymphotactin | -0.823 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q9UBD3 | XCL2 | Cytokine SCM-1 beta | -0.797 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q9UBD3 | XCL2 | Cytokine SCM-1 beta | 0.83 | P08311 | CTSG | Cathepsin G | Q9UBD3 | XCL2 | Cytokine SCM-1 beta | -0.823 | O00767 | SCD | Stearoyl-CoA desaturase | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.713 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.702 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.769 | P08311 | CTSG | Cathepsin G | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.736 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | 0.713 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 |
| Rosoxacin | hsa04062 | Chemokine signaling pathway | 9.82E-09 | 23 | P25024, P25025, P09341, P19875, P47992, Q9UBD3, P09769, P07948, P42338, P19174, P62873, P63218, P50151, P43250, Q08881, Q7LDG7, Q13009, P14598, P22694, P42224, P25963, P49841, Q8WYR1 | CXCR1, CXCR2, CXCL1, CXCL2, XCL1, XCL2, FGR, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, ITK, RASGRP2, TIAM1, NCF1, PRKACB, STAT1, NFKBIA, GSK3B, PIK3R5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | 0.901 | Q13547 | HDAC1 | Histone deacetylase 1 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.803 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.917 | Q13547 | HDAC1 | Histone deacetylase 1 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | -0.719 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.859 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P47992 | XCL1 | Lymphotactin | -0.797 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q9UBD3 | XCL2 | Cytokine SCM-1 beta | -0.797 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P09769 | FGR | Tyrosine-protein kinase Fgr | 0.796 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.713 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.852 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.971 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | Q13547 | HDAC1 | Histone deacetylase 1 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.864 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.737 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | Q13547 | HDAC1 | Histone deacetylase 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.716 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | -0.701 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P43250 | GRK6 | G protein-coupled receptor kinase 6 | -0.775 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43250 | GRK6 | G protein-coupled receptor kinase 6 | 0.818 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.847 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.792 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.706 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.908 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.755 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.758 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.841 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.794 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 |
| Rosoxacin | hsa04064 | NF-kappa B signaling pathway | 1.42E-15 | 25 | P10415, Q13489, P25963, P51617, O00463, P14778, P01584, P01375, P19174, Q04759, Q9UDY8, Q13077, P67870, Q16548, P07948, P06239, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, IL1R1, IL1B, TNF, PLCG1, PRKCQ, MALT1, TRAF1, CSNK2B, BCL2A1, LYN, LCK, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04183 | TK1 | Thymidine kinase, cytosolic | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.763 | P08246 | ELA2 | Neutrophil elastase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.942 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P08246 | ELA2 | Neutrophil elastase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.716 | P08246 | ELA2 | Neutrophil elastase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.701 | P04183 | TK1 | Thymidine kinase, cytosolic | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.756 | P08246 | ELA2 | Neutrophil elastase | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.734 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.896 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P08246 | ELA2 | Neutrophil elastase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.814 | P08311 | CTSG | Cathepsin G | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.853 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P01584 | IL1B | Interleukin-1 beta | 0.762 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P04183 | TK1 | Thymidine kinase, cytosolic | Q04759 | PRKCQ | Protein kinase C theta type | -0.729 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.807 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P08246 | ELA2 | Neutrophil elastase | Q04759 | PRKCQ | Protein kinase C theta type | -0.748 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P04183 | TK1 | Thymidine kinase, cytosolic | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.738 | P08246 | ELA2 | Neutrophil elastase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.896 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | P08246 | ELA2 | Neutrophil elastase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.725 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P67870 | CSNK2B | Casein kinase II subunit beta | 0.709 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.889 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | P08246 | ELA2 | Neutrophil elastase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.766 | P08311 | CTSG | Cathepsin G | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.713 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.809 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | P04183 | TK1 | Thymidine kinase, cytosolic | Q13315 | ATM | Serine-protein kinase ATM | -0.765 | P08246 | ELA2 | Neutrophil elastase | Q13315 | ATM | Serine-protein kinase ATM | -0.742 | P08311 | CTSG | Cathepsin G | Q13315 | ATM | Serine-protein kinase ATM | -0.709 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.702 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.739 | P04183 | TK1 | Thymidine kinase, cytosolic | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.718 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.805 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | P08246 | ELA2 | Neutrophil elastase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.7 | P08311 | CTSG | Cathepsin G | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.799 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.727 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.727 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P04183 | TK1 | Thymidine kinase, cytosolic | P09341 | CXCL1 | Growth-regulated alpha protein | 0.722 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.859 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | P08311 | CTSG | Cathepsin G | P09341 | CXCL1 | Growth-regulated alpha protein | 0.877 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | Q06643 | LTB | Lymphotoxin-beta | 0.74 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.763 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.753 |
| Rosoxacin | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | | Rosoxacin | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Rosoxacin | hsa04070 | Phosphatidylinositol signaling system | 5.33E-07 | 9 | P19174, P0DP23, P42338, O14986, P23743, Q16760, P48426, P27987, P17252 | PLCG1, CALM1, PIK3CB, PIP5K1B, DGKA, DGKD, PIP4K2A, ITPKB, PRKCA | More | | Rosoxacin | hsa04071 | Sphingolipid signaling pathway | 7.33E-06 | 10 | P17252, P21453, Q9H228, P01375, Q13510, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | PRKCA, S1PR1, EDG8, TNF, ASAH1, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | | Rosoxacin | hsa04072 | Phospholipase D signaling pathway | 1.51E-05 | 16 | P31751, P42338, Q9UQC2, P43657, P25024, P25025, P19174, O14986, Q14344, Q8WYR1, Q15438, Q08828, P51828, P23743, Q16760, Q9NRA1 | AKT2, PIK3CB, GAB2, P2RY5, CXCR1, CXCR2, PLCG1, PIP5K1B, GNA13, PIK3R5, PSCD1, ADCY1, ADCY7, DGKA, DGKD, PDGFC | More | | Rosoxacin | hsa04080 | Neuroactive ligand-receptor interaction | 1.35E-05 | 10 | P08311, Q15722, P21453, Q9H228, P43657, O00398, P21462, P21730, P07550, P35318 | CTSG, LTB4R, S1PR1, EDG8, P2RY5, P2RY10, FPR1, C5AR1, ADRB2, ADM | More | | Rosoxacin | hsa04110 | Cell cycle | 2.16E-06 | 8 | P06493, O60566, O75293, P30304, P33981, P42773, P01106, Q13547 | CDK1, BUB1B, GADD45B, CDC25A, TTK, CDKN2C, MYC, HDAC1 | More | | Rosoxacin | hsa04114 | Oocyte meiosis | 1.78E-04 | 10 | P51812, Q02750, P0DP23, P16298, Q17RY0, Q08828, P51828, Q13362, Q14738, P08069 | RPS6KA3, MAP2K1, CALM1, PPP3CB, CPEB4, ADCY1, ADCY7, PPP2R5C, PPP2R5D, IGF1R | More | | Rosoxacin | hsa04115 | p53 signaling pathway | 6.07E-05 | 7 | P24522, Q13315, P31350, Q53FA7, P06493, O95067, P10415 | GADD45A, ATM, RRM2, TP53I3, CDK1, CCNB2, BCL2 | More | | Rosoxacin | hsa04120 | Ubiquitin mediated proteolysis | 1.28E-05 | 8 | Q9UBT2, Q14145, Q13042, P62837, Q15751, O95071, Q14669, P0CG47 | SAE2, KEAP1, CDC16, UBE2D2, HERC1, UBR5, TRIP12, UBB | More | | Rosoxacin | hsa04122 | Sulfur relay system | 4.01E-04 | 1 | Q16762 | TST | More | | Rosoxacin | hsa04136 | Autophagy - other | 3.53E-02 | 1 | O94817 | ATG12 | More | | Rosoxacin | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | | Rosoxacin | hsa04140 | Autophagy - animal | 2.65E-04 | 13 | P08069, Q9Y4H2, P31751, Q7L523, Q9NQL2, O75460, P22694, Q14643, P10415, Q9H1Y0, Q04759, Q96GC9, Q8TEV9 | IGF1R, IRS2, AKT2, RRAGA, RRAGD, ERN1, PRKACB, ITPR1, BCL2, ATG5, PRKCQ, TMEM49, SMCR8 | More | | Rosoxacin | hsa04141 | Protein processing in endoplasmic reticulum | 2.94E-04 | 8 | P18848, Q15437, Q99941, O75460, P11142, Q9H3Z4, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, SAR1A | More | | Rosoxacin | hsa04142 | Lysosome | 2.01E-03 | 6 | P22304, P38571, Q13510, Q9UJJ9, P07602, P49279 | IDS, LIPA, ASAH1, GNPTG, PSAP, SLC11A1 | More | | Rosoxacin | hsa04144 | Endocytosis | 6.92E-04 | 7 | P0DMV8, Q9H444, O75351, P62491, Q8WU79, Q14161, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SMAP1L, GIT2, SNX12 | More | | Rosoxacin | hsa04145 | Phagosome | 3.01E-07 | 10 | Q15080, P14598, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Rosoxacin | hsa04150 | mTOR signaling pathway | 7.74E-03 | 4 | P08069, Q02750, Q9NQL2, P51812 | IGF1R, MAP2K1, RRAGD, RPS6KA3 | More | | Rosoxacin | hsa04151 | PI3K-Akt signaling pathway | 2.59E-07 | 29 | P62753, P42338, P43657, P01106, O43521, P27348, P20827, Q9NRA1, P49767, Q13362, P07900, P08238, Q8WYR1, P62873, P63218, P50151, P16144, O15335, Q13751, P22105, P14784, P23458, P01568, Q99941, P18848, P17252, O00141, Q6ZUJ8, P30281 | RPS6, PIK3CB, P2RY5, MYC, BCL2L11, YWHAQ, EFNA1, PDGFC, VEGFC, PPP2R5C, HSP90AA1, HSP90AB1, PIK3R5, GNB1, GNG5, GNG10, ITGB4, CHAD, LAMB3, TNXB, IL2RB, JAK1, IFNA21, CREBL1, ATF4, PRKCA, SGK, PIK3AP1, CCND3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P62753 | RPS6 | 40S ribosomal protein S6 | 0.722 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01106 | MYC | Myc proto-oncogene protein | 0.719 | P42892 | ECE1 | Endothelin-converting enzyme 1 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.736 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P27348 | YWHAQ | 14-3-3 protein theta | 0.833 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P20827 | EFNA1 | Ephrin-A1 | -0.872 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P20827 | EFNA1 | Ephrin-A1 | -0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P20827 | EFNA1 | Ephrin-A1 | 0.715 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q9NRA1 | PDGFC | Platelet-derived growth factor C | -0.702 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.871 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P49767 | VEGFC | Vascular endothelial growth factor C | -0.778 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.733 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 1 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.802 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.926 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P16144 | ITGB4 | Integrin beta-4 | -0.705 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O15335 | CHAD | Chondroadherin | -0.719 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O15335 | CHAD | Chondroadherin | -0.704 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O15335 | CHAD | Chondroadherin | 0.795 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.705 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P22105 | TNXB | Tenascin-X | 0.777 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.865 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.912 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P42892 | ECE1 | Endothelin-converting enzyme 1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.797 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.777 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.783 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.709 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.747 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 |
| Rosoxacin | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Rosoxacin | hsa04210 | Apoptosis | 1.54E-03 | 11 | Q13315, P10415, Q13489, O76075, P25963, P01375, P24522, Q16548, Q13077, P43234, Q14643 | ATM, BCL2, BIRC3, DFFB, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, CTSO, ITPR1 | More | | Rosoxacin | hsa04211 | Longevity regulating pathway | 3.68E-04 | 6 | P31751, P08069, Q08828, P51828, Q99941, P18848 | AKT2, IGF1R, ADCY1, ADCY7, CREBL1, ATF4 | More | | Rosoxacin | hsa04213 | Longevity regulating pathway - multiple species | 7.65E-06 | 9 | P31751, P42338, P08069, Q9Y4H2, Q08828, P51828, P0DMV8, P11142, Q13547 | AKT2, PIK3CB, IGF1R, IRS2, ADCY1, ADCY7, HSPA1A, HSPA8, HDAC1 | More | | Rosoxacin | hsa04217 | Necroptosis | 3.97E-05 | 15 | P01375, P01568, P48023, Q13489, Q9NQC7, P42224, Q14765, P07900, P08238, P15104, P01584, Q6FI13, Q99878, Q9H444, O43633 | TNF, IFNA21, FASLG, BIRC3, CYLD, STAT1, STAT4, HSP90AA1, HSP90AB1, GLUL, IL1B, H2AC18; H2AC19, H2AC14, CHMP4B, CHMP2A | More | | Rosoxacin | hsa04260 | Cardiac muscle contraction | 4.49E-02 | 3 | P67936, P13073, P12074 | TPM4, COX4I1, COX6A1 | More | | Rosoxacin | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.74E-06 | 10 | Q08828, P51828, P31751, Q99941, P18848, Q13362, Q14738, P0DP23, Q13557, P23634 | ADCY1, ADCY7, AKT2, CREBL1, ATF4, PPP2R5C, PPP2R5D, CALM1, CAMK2D, ATP2B4 | More | | Rosoxacin | hsa04270 | Vascular smooth muscle contraction | 2.59E-04 | 8 | P24723, Q04759, Q14643, P0DP23, Q08828, P22694, P35579, P35318 | PRKCH, PRKCQ, ITPR1, CALM1, ADCY1, PRKACB, MYH9, ADM | More | | Rosoxacin | hsa04310 | Wnt signaling pathway | 5.60E-03 | 3 | P30279, Q13485, O43318 | CCND2, SMAD4, MAP3K7 | More | | Rosoxacin | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Rosoxacin | hsa04340 | Hedgehog signaling pathway | 2.62E-03 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Rosoxacin | hsa04360 | Axon guidance | 2.88E-06 | 8 | P16333, P20827, O95631, P17252, P42338, P07332, P23528, P19174 | NCK1, EFNA1, NTN1, PRKCA, PIK3CB, FES, CFL1, PLCG1 | More | | Rosoxacin | hsa04370 | VEGF signaling pathway | 1.04E-04 | 6 | P19174, P16298, P42338, P17252, Q05397, Q02750 | PLCG1, PPP3CB, PIK3CB, PRKCA, PTK2, MAP2K1 | More | | Rosoxacin | hsa04371 | Apelin signaling pathway | 1.14E-05 | 13 | P62873, P63218, P50151, Q8WYR1, P31751, Q08828, P51828, Q13370, Q14814, Q14344, Q13485, P84022, P0DP23 | GNB1, GNG5, GNG10, PIK3R5, AKT2, ADCY1, ADCY7, PDE3B, MEF2D, GNA13, SMAD4, SMAD3, CALM1 | More | | Rosoxacin | hsa04380 | Osteoclast differentiation | 5.27E-04 | 10 | Q9NQC7, Q9UQC2, Q16539, P23458, P31751, P01584, P14778, O75015, P01375, Q8N149 | CYLD, GAB2, MAPK14, JAK1, AKT2, IL1B, IL1R1, FCGR3B, TNF, LILRA2 | More | | Rosoxacin | hsa04392 | Hippo signaling pathway - multiple species | 3.01E-02 | 1 | Q6V0I7 | FAT4 | More | | Rosoxacin | hsa04510 | Focal adhesion | 2.69E-03 | 10 | P16144, O75369, P42338, Q15942, P17252, O15335, Q13751, Q13489, P08069, P49767 | ITGB4, FLNB, PIK3CB, ZYX, PRKCA, CHAD, LAMB3, BIRC3, IGF1R, VEGFC | More | | Rosoxacin | hsa04512 | ECM-receptor interaction | 2.00E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Rosoxacin | hsa04514 | Cell adhesion molecules | 7.16E-05 | 4 | P23229, P16109, P30511, O00501 | ITGA6, SELP, HLA-F, CLDN5 | More | | Rosoxacin | hsa04520 | Adherens junction | 1.81E-03 | 3 | Q13485, O43318, P08069 | SMAD4, MAP3K7, IGF1R | More | | Rosoxacin | hsa04530 | Tight junction | 2.74E-04 | 6 | Q8TEU7, P16989, P56750, O00501, Q14247, P24844 | RAPGEF6, CSDA, CLDN17, CLDN5, CTTN, MYL9 | More | | Rosoxacin | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P08069 | IGF1R | More | | Rosoxacin | hsa04610 | Complement and coagulation cascades | 3.71E-08 | 2 | P00734, P0C0L4 | F2, C4A | More | | Rosoxacin | hsa04611 | Platelet activation | 1.53E-05 | 6 | Q9Y490, P08514, Q15746, Q08828, Q8WYR1, P07359 | TLN1, ITGA2B, MYLK, ADCY1, PIK3R5, GP1BA | More | | Rosoxacin | hsa04612 | Antigen processing and presentation | 4.25E-08 | 9 | P13765, P48382, P26715, P26717, Q07444, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRC3, KLRD1, KLRC4, CD8A, TNF | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04183 | TK1 | Thymidine kinase, cytosolic | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.75 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P04183 | TK1 | Thymidine kinase, cytosolic | P48382 | RFX5 | DNA-binding protein RFX5 | -0.739 | P14780 | MMP9 | Matrix metalloproteinase-9 | P48382 | RFX5 | DNA-binding protein RFX5 | -0.874 | P08311 | CTSG | Cathepsin G | P48382 | RFX5 | DNA-binding protein RFX5 | -0.794 | P04183 | TK1 | Thymidine kinase, cytosolic | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.707 | P14780 | MMP9 | Matrix metalloproteinase-9 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.867 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.915 | P08311 | CTSG | Cathepsin G | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.867 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.726 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 | P04183 | TK1 | Thymidine kinase, cytosolic | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.707 | P14780 | MMP9 | Matrix metalloproteinase-9 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.867 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.915 | P08311 | CTSG | Cathepsin G | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.867 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.726 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.718 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.829 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.837 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.941 | P08311 | CTSG | Cathepsin G | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.812 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.78 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | P14780 | MMP9 | Matrix metalloproteinase-9 | O43908 | KLRC4 | NKG2-F type II integral membrane protein | -0.792 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.742 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.892 | P08311 | CTSG | Cathepsin G | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.826 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.763 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 |
| Rosoxacin | hsa04613 | Neutrophil extracellular trap formation | 5.96E-08 | 30 | P42338, P19174, P17252, P16109, P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q6FI13, Q99878, Q93077, P62807, Q93079, O60814, P68431, P21796, P14598, Q15080, P20160, P08311, P49913, O75015, P21730, P08514, P21462, P07359, O43315, Q16539 | PIK3CB, PLCG1, PRKCA, SELP, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC18; H2AC19, H2AC14, HIST1H2AC, HIST1H2BC, H2BC9, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, VDAC1, NCF1, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, ITGA2B, FPR1, GP1BA, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | P08246 | ELA2 | Neutrophil elastase | P17252 | PRKCA | Protein kinase C alpha type | -0.735 | P16109 | SELP | P-selectin | P16109 | SELP | P-selectin | 1 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P11215 | ITGAM | Integrin alpha-M | -0.877 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | P08246 | ELA2 | Neutrophil elastase | O60603 | TLR2 | Toll-like receptor 2 | 0.853 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | P08246 | ELA2 | Neutrophil elastase | P05164 | MPO | Myeloperoxidase | 0.903 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P05164 | MPO | Myeloperoxidase | -0.866 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | P08246 | ELA2 | Neutrophil elastase | P08246 | ELA2 | Neutrophil elastase | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08246 | ELA2 | Neutrophil elastase | -0.76 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.9 | P08246 | ELA2 | Neutrophil elastase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.889 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | -0.819 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13547 | HDAC1 | Histone deacetylase 1 | 0.701 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.74 | P08246 | ELA2 | Neutrophil elastase | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.907 | P16109 | SELP | P-selectin | Q99878 | H2AC14 | Histone H2A type 1-J | 0.839 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | -0.703 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | -0.703 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q93079 | H2BC9 | Histone H2B type 1-H | 0.756 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 0.72 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.755 | P08246 | ELA2 | Neutrophil elastase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.762 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.869 | P08246 | ELA2 | Neutrophil elastase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.945 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.731 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20160 | AZU1 | Azurocidin | 0.734 | P08246 | ELA2 | Neutrophil elastase | P20160 | AZU1 | Azurocidin | 0.842 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20160 | AZU1 | Azurocidin | -0.799 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08311 | CTSG | Cathepsin G | 0.79 | P08246 | ELA2 | Neutrophil elastase | P08311 | CTSG | Cathepsin G | 0.792 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08311 | CTSG | Cathepsin G | -0.811 | P08246 | ELA2 | Neutrophil elastase | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.807 | P14780 | MMP9 | Matrix metalloproteinase-9 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.928 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.942 | P08246 | ELA2 | Neutrophil elastase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.703 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | -0.772 | P16109 | SELP | P-selectin | P08514 | ITGA2B | Integrin alpha-IIb | 0.781 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.912 | P08246 | ELA2 | Neutrophil elastase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.85 | P16109 | SELP | P-selectin | P07359 | GP1BA | Platelet glycoprotein Ib alpha chain | 0.794 | P14780 | MMP9 | Matrix metalloproteinase-9 | O43315 | AQP9 | Aquaporin-9 | 0.837 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 |
| Rosoxacin | hsa04620 | Toll-like receptor signaling pathway | 4.12E-04 | 7 | P01568, P01584, P31751, P42224, P25963, P42338, Q8NHW4 | IFNA21, IL1B, AKT2, STAT1, NFKBIA, PIK3CB, CCL4L2 | More | | Rosoxacin | hsa04621 | NOD-like receptor signaling pathway | 7.89E-08 | 20 | P01584, P07900, Q16539, Q14643, P23458, P21796, P25963, Q9H3M7, Q13489, P10599, Q9H1Y0, P43490, O00463, P10415, P29728, Q05823, P01375, P09341, P49913, P12838 | IL1B, HSP90AA1, MAPK14, ITPR1, JAK1, VDAC1, NFKBIA, TXNIP, BIRC3, TXN, ATG5, PBEF1, TRAF5, BCL2, OAS2, RNASEL, TNF, CXCL1, CAMP, DEFA4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P01584 | IL1B | Interleukin-1 beta | 0.786 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.709 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.849 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.763 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.81 | P08246 | ELA2 | Neutrophil elastase | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.816 | P42892 | ECE1 | Endothelin-converting enzyme 1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.797 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | -0.705 | P08246 | ELA2 | Neutrophil elastase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.701 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q9H3M7 | TXNIP | Thioredoxin-interacting protein | 0.747 | P08246 | ELA2 | Neutrophil elastase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.716 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P10599 | TXN | Thioredoxin | 0.847 | P14780 | MMP9 | Matrix metalloproteinase-9 | P10599 | TXN | Thioredoxin | 0.713 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q9H1Y0 | ATG5 | Autophagy protein 5 | -0.726 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9H1Y0 | ATG5 | Autophagy protein 5 | -0.895 | P08246 | ELA2 | Neutrophil elastase | Q9H1Y0 | ATG5 | Autophagy protein 5 | -0.759 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.742 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.964 | P14780 | MMP9 | Matrix metalloproteinase-9 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.94 | P08246 | ELA2 | Neutrophil elastase | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.702 | P42892 | ECE1 | Endothelin-converting enzyme 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.815 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.896 | P14780 | MMP9 | Matrix metalloproteinase-9 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.917 | P08246 | ELA2 | Neutrophil elastase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.814 | P14780 | MMP9 | Matrix metalloproteinase-9 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.765 | P08246 | ELA2 | Neutrophil elastase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.942 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P29728 | OAS2 | 2'-5'-oligoadenylate synthase 2 | -0.72 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q05823 | RNASEL | 2-5A-dependent ribonuclease | 0.73 | P08246 | ELA2 | Neutrophil elastase | Q05823 | RNASEL | 2-5A-dependent ribonuclease | 0.734 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.859 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.771 | P08246 | ELA2 | Neutrophil elastase | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.807 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.842 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.858 | P08246 | ELA2 | Neutrophil elastase | P12838 | DEFA4 | Neutrophil defensin 4 | 0.709 |
| Rosoxacin | hsa04623 | Cytosolic DNA-sensing pathway | 9.72E-08 | 5 | P01584, P01568, P25963, Q9Y535, Q8NHW4 | IL1B, IFNA21, NFKBIA, POLR3H, CCL4L2 | More | | Rosoxacin | hsa04625 | C-type lectin receptor signaling pathway | 7.57E-05 | 11 | Q9ULY5, P01584, Q9NQC7, P42224, P20749, P25963, P01375, P42338, P31751, P0DP23, Q16539 | CLEC4E, IL1B, CYLD, STAT1, BCL3, NFKBIA, TNF, PIK3CB, AKT2, CALM1, MAPK14 | More | | Rosoxacin | hsa04630 | JAK-STAT signaling pathway | 4.54E-02 | 3 | P31751, P23458, Q13651 | AKT2, JAK1, IL10RA | More | | Rosoxacin | hsa04640 | Hematopoietic cell lineage | 7.53E-08 | 16 | P13612, P14778, P27930, P11215, P15144, P11836, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375, P09603 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF, CSF1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P13612 | ITGA4 | Integrin alpha-4 | -0.88 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13612 | ITGA4 | Integrin alpha-4 | 0.735 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.906 | Q13547 | HDAC1 | Histone deacetylase 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.837 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.813 | P08311 | CTSG | Cathepsin G | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P11215 | ITGAM | Integrin alpha-M | -0.751 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P15144 | ANPEP | Aminopeptidase N | 0.764 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P15144 | ANPEP | Aminopeptidase N | -0.765 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P11836 | MS4A1 | B-lymphocyte antigen CD20 | -0.717 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P25063 | CD24 | Signal transducer CD24 | 0.717 | Q13547 | HDAC1 | Histone deacetylase 1 | P25063 | CD24 | Signal transducer CD24 | -0.706 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P25063 | CD24 | Signal transducer CD24 | -0.838 | P08311 | CTSG | Cathepsin G | P25063 | CD24 | Signal transducer CD24 | 0.902 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.782 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.731 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.783 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.892 | P08311 | CTSG | Cathepsin G | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.826 | P06493 | CDK1 | Cyclin-dependent kinase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.732 | P06493 | CDK1 | Cyclin-dependent kinase 1 | P06127 | CD5 | T-cell surface glycoprotein CD5 | -0.739 | Q13547 | HDAC1 | Histone deacetylase 1 | P09564 | CD7 | T-cell antigen CD7 | 0.738 | P06493 | CDK1 | Cyclin-dependent kinase 1 | P09564 | CD7 | T-cell antigen CD7 | -0.735 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.748 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | 0.713 |
| Rosoxacin | hsa04650 | Natural killer cell mediated cytotoxicity | 2.59E-15 | 17 | P16298, P50591, P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q02750, Q13241, P26718, O14931, O75015, P26717, Q07444, P26715 | PPP3CB, TNFSF10, PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, MAP2K1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC3, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P11511 | CYP19A1 | Aromatase | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.706 | P11511 | CYP19A1 | Aromatase | P50591 | TNFSF10 | Tumor necrosis factor ligand superfamily member 10 | 0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | P01375 | TNF | Tumor necrosis factor | -0.709 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.769 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.809 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.769 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.771 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.848 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.922 | P08311 | CTSG | Cathepsin G | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.92 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.869 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.881 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.797 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P11511 | CYP19A1 | Aromatase | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.783 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.846 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.941 | P08311 | CTSG | Cathepsin G | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.812 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.78 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.726 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.931 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.858 | P08311 | CTSG | Cathepsin G | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.875 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.767 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.762 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.71 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.818 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.855 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.716 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.833 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.846 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.915 | P08311 | CTSG | Cathepsin G | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.867 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.726 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.737 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.718 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.829 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.846 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.915 | P08311 | CTSG | Cathepsin G | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.867 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.726 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.737 |
| Rosoxacin | hsa04657 | IL-17 signaling pathway | 1.18E-06 | 9 | P07900, O00463, Q16539, P49841, P09341, P14780, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF, IL1B | More | | Rosoxacin | hsa04658 | Th1 and Th2 cell differentiation | 5.84E-24 | 16 | P25963, Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, P42224, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | NFKBIA, PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT1, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.807 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q04759 | PRKCQ | Protein kinase C theta type | 0.869 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.734 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.782 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.839 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.862 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.881 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.797 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.731 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.812 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.849 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.762 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.708 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.809 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.769 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.767 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.771 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.75 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.756 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.861 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.821 | P08311 | CTSG | Cathepsin G | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.81 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.765 | P14780 | MMP9 | Matrix metalloproteinase-9 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.747 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.878 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.849 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.927 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.808 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.858 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.705 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.912 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.795 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.748 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.769 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.804 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.884 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.702 | P30304 | CDC25A | M-phase inducer phosphatase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.721 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.73 |
| Rosoxacin | hsa04659 | Th17 cell differentiation | 1.15E-16 | 20 | P25963, Q04759, Q16539, P19174, P01730, P06239, P42224, P14784, P13765, P14778, Q9HBE5, P40189, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, MAPK14, PLCG1, CD4, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL21R, IL6ST, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.807 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q04759 | PRKCQ | Protein kinase C theta type | 0.869 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.734 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.849 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.762 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.708 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.809 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.769 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.767 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.771 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.841 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.75 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.865 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.912 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.795 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.748 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.764 | P08311 | CTSG | Cathepsin G | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.763 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.748 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.927 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.858 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.705 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.765 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.878 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.849 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.802 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.926 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.782 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.839 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.838 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.731 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.812 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.881 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.797 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 |
| Rosoxacin | hsa04660 | T cell receptor signaling pathway | 7.52E-16 | 19 | P01375, P25963, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P16333, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | TNF, NFKBIA, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, NCK1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P08246 | ELA2 | Neutrophil elastase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.701 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.767 | P08246 | ELA2 | Neutrophil elastase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.896 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.807 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P08246 | ELA2 | Neutrophil elastase | Q04759 | PRKCQ | Protein kinase C theta type | -0.748 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q04759 | PRKCQ | Protein kinase C theta type | 0.869 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.734 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P08246 | ELA2 | Neutrophil elastase | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | -0.854 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.824 | P14780 | MMP9 | Matrix metalloproteinase-9 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.792 | P08246 | ELA2 | Neutrophil elastase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.724 | P08311 | CTSG | Cathepsin G | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.705 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.737 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.847 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.855 | P08246 | ELA2 | Neutrophil elastase | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.782 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.808 | P08311 | CTSG | Cathepsin G | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.866 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.752 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.762 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P16333 | NCK1 | Cytoplasmic protein NCK1 | -0.781 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.782 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.862 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.881 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.797 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.731 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.812 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.708 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.783 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.742 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.892 | P08311 | CTSG | Cathepsin G | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.826 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.763 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.858 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.793 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.795 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.809 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.769 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.767 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.771 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.849 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.794 | P14780 | MMP9 | Matrix metalloproteinase-9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.75 |
| Rosoxacin | hsa04662 | B cell receptor signaling pathway | 5.25E-04 | 6 | P25963, P42338, P60033, P07948, P21854, Q8N149 | NFKBIA, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Rosoxacin | hsa04664 | Fc epsilon RI signaling pathway | 8.84E-07 | 9 | P01375, Q16539, P42338, P17252, Q9UQC2, P07948, P19174, P09917, P20292 | TNF, MAPK14, PIK3CB, PRKCA, GAB2, LYN, PLCG1, ALOX5, ALOX5AP | More | | Rosoxacin | hsa04666 | Fc gamma R-mediated phagocytosis | 4.81E-06 | 8 | P07948, P42338, P19174, P23528, P06396, O14494, P14598, P17252 | LYN, PIK3CB, PLCG1, CFL1, GSN, PLPP1, NCF1, PRKCA | More | | Rosoxacin | hsa04668 | TNF signaling pathway | 2.41E-04 | 11 | P01375, O00463, Q13489, Q16539, P25963, Q99941, P01584, P20749, Q13077, P14780, O95429 | TNF, TRAF5, BIRC3, MAPK14, NFKBIA, CREBL1, IL1B, BCL3, TRAF1, MMP9, BAG4 | More | | Rosoxacin | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | | Rosoxacin | hsa04672 | Intestinal immune network for IgA production | 1.62E-02 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Rosoxacin | hsa04710 | Circadian rhythm | 1.14E-03 | 1 | O15516 | CLOCK | More | | Rosoxacin | hsa04713 | Circadian entrainment | 1.64E-04 | 8 | O15399, P0DP23, P17252, P62873, P63218, P50151, Q08828, P51828 | GRIN2D, CALM1, PRKCA, GNB1, GNG5, GNG10, ADCY1, ADCY7 | More | | Rosoxacin | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Rosoxacin | hsa04720 | Long-term potentiation | 1.71E-03 | 6 | P16298, P0DP23, P51812, P18848, Q08828, Q02750 | PPP3CB, CALM1, RPS6KA3, ATF4, ADCY1, MAP2K1 | More | | Rosoxacin | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Rosoxacin | hsa04723 | Retrograde endocannabinoid signaling | 9.74E-03 | 7 | Q14643, P48169, P62873, P63218, P50151, P22694, Q16539 | ITPR1, GABRA4, GNB1, GNG5, GNG10, PRKACB, MAPK14 | More | | Rosoxacin | hsa04724 | Glutamatergic synapse | 6.21E-04 | 6 | O15399, P17252, P62873, P63218, P50151, P15104 | GRIN2D, PRKCA, GNB1, GNG5, GNG10, GLUL | More | | Rosoxacin | hsa04725 | Cholinergic synapse | 1.62E-05 | 10 | Q08828, P51828, P17252, P62873, P63218, P50151, P18848, Q13557, P42338, P31751 | ADCY1, ADCY7, PRKCA, GNB1, GNG5, GNG10, ATF4, CAMK2D, PIK3CB, AKT2 | More | | Rosoxacin | hsa04726 | Serotonergic synapse | 2.54E-02 | 5 | P17252, P62873, P50151, P33260, P09917 | PRKCA, GNB1, GNG10, CYP2C18, ALOX5 | More | | Rosoxacin | hsa04727 | GABAergic synapse | 1.70E-04 | 6 | P62873, P63218, P50151, P48169, P15104, P17252 | GNB1, GNG5, GNG10, GABRA4, GLUL, PRKCA | More | | Rosoxacin | hsa04728 | Dopaminergic synapse | 1.01E-03 | 7 | P31751, Q99941, P18848, Q13557, Q13362, Q14738, P0DP23 | AKT2, CREBL1, ATF4, CAMK2D, PPP2R5C, PPP2R5D, CALM1 | More | | Rosoxacin | hsa04730 | Long-term depression | 3.01E-03 | 2 | Q14344, P08069 | GNA13, IGF1R | More | | Rosoxacin | hsa04742 | Taste transduction | 4.80E-02 | 1 | P48169 | GABRA4 | More | | Rosoxacin | hsa04744 | Phototransduction | 6.54E-06 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Rosoxacin | hsa04750 | Inflammatory mediator regulation of TRP channels | 2.47E-07 | 13 | P14778, P01584, Q08828, P51828, P22694, Q13557, Q16539, P19174, P42338, Q14643, P24723, Q04759, P0DP23 | IL1R1, IL1B, ADCY1, ADCY7, PRKACB, CAMK2D, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ, CALM1 | More | | Rosoxacin | hsa04810 | Regulation of actin cytoskeleton | 4.14E-03 | 7 | P12814, Q13009, P42338, P23229, P11215, Q14344, Q9NRA1 | ACTN1, TIAM1, PIK3CB, ITGA6, ITGAM, GNA13, PDGFC | More | | Rosoxacin | hsa04911 | Insulin secretion | 1.68E-06 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Rosoxacin | hsa04912 | GnRH signaling pathway | 5.32E-05 | 6 | Q08828, P51828, P18848, Q13557, Q9Y6R4, P0DP23 | ADCY1, ADCY7, ATF4, CAMK2D, MAP3K4, CALM1 | More | | Rosoxacin | hsa04913 | Ovarian steroidogenesis | 1.16E-02 | 1 | P08069 | IGF1R | More | | Rosoxacin | hsa04914 | Progesterone-mediated oocyte maturation | 1.22E-05 | 9 | P08069, Q17RY0, P42338, Q13370, Q9UJX4, P30304, P08238, P51812, Q02750 | IGF1R, CPEB4, PIK3CB, PDE3B, ANAPC5, CDC25A, HSP90AB1, RPS6KA3, MAP2K1 | More | | Rosoxacin | hsa04915 | Estrogen signaling pathway | 2.12E-08 | 10 | Q99941, P18848, Q08828, P51828, P31751, P07900, P0DMV8, P11142, P0DP23, Q15788 | CREBL1, ATF4, ADCY1, ADCY7, AKT2, HSP90AA1, HSPA1A, HSPA8, CALM1, NCOA1 | More | | Rosoxacin | hsa04916 | Melanogenesis | 3.48E-03 | 6 | P0DP23, Q9UJU2, Q08828, P51828, P17252, P04628 | CALM1, LEF1, ADCY1, ADCY7, PRKCA, WNT1 | More | | Rosoxacin | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | | Rosoxacin | hsa04920 | Adipocytokine signaling pathway | 4.49E-02 | 4 | P25963, P33121, Q04759, P01375 | NFKBIA, ACSL1, PRKCQ, TNF | More | | Rosoxacin | hsa04921 | Oxytocin signaling pathway | 3.84E-03 | 4 | Q15746, Q08828, Q96RR4, Q8WYR1 | MYLK, ADCY1, CAMKK2, PIK3R5 | More | | Rosoxacin | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | | Rosoxacin | hsa04923 | Regulation of lipolysis in adipocytes | 2.89E-04 | 6 | Q08828, P51828, P07550, P42338, Q9Y4H2, P31751 | ADCY1, ADCY7, ADRB2, PIK3CB, IRS2, AKT2 | More | | Rosoxacin | hsa04924 | Renin secretion | 8.07E-06 | 5 | P22694, P07550, Q14643, Q13370, P0DP23 | PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | | Rosoxacin | hsa04925 | Aldosterone synthesis and secretion | 8.33E-07 | 7 | Q99941, P18848, Q08828, P51828, P0DP23, Q13557, P23634 | CREBL1, ATF4, ADCY1, ADCY7, CALM1, CAMK2D, ATP2B4 | More | | Rosoxacin | hsa04926 | Relaxin signaling pathway | 6.94E-07 | 13 | P31751, P25963, P42338, P62873, P63218, P50151, Q99941, P18848, P49767, Q08828, P51828, P17252, P30679 | AKT2, NFKBIA, PIK3CB, GNB1, GNG5, GNG10, CREBL1, ATF4, VEGFC, ADCY1, ADCY7, PRKCA, GNA15 | More | | Rosoxacin | hsa04927 | Cortisol synthesis and secretion | 1.76E-04 | 4 | Q99941, P18848, Q08828, P51828 | CREBL1, ATF4, ADCY1, ADCY7 | More | | Rosoxacin | hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.09E-03 | 7 | Q14643, P51828, P22694, P23771, Q99941, P18848, P10415 | ITPR1, ADCY7, PRKACB, GATA3, CREBL1, ATF4, BCL2 | More | | Rosoxacin | hsa04932 | Non-alcoholic fatty liver disease | 2.72E-06 | 12 | P31751, P01375, P49841, O43521, P18848, P48023, O75460, P01584, P13073, P12074, O15239, O95298 | AKT2, TNF, GSK3B, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFA1, NDUFC2 | More | | Rosoxacin | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.76E-03 | 7 | P84022, Q13485, P42224, P42338, P49767, P17252, P19174 | SMAD3, SMAD4, STAT1, PIK3CB, VEGFC, PRKCA, PLCG1 | More | | Rosoxacin | hsa04934 | Cushing syndrome | 2.24E-06 | 6 | Q99941, P18848, Q08828, P51828, O15169, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, AXIN1, CAMK2D | More | | Rosoxacin | hsa04935 | Growth hormone synthesis, secretion and action | 1.32E-03 | 5 | Q08828, P51828, Q99941, P18848, P31751 | ADCY1, ADCY7, CREBL1, ATF4, AKT2 | More | | Rosoxacin | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Rosoxacin | hsa04950 | Maturity onset diabetes of the young | 2.03E-02 | 1 | P35557 | GCK | More | | Rosoxacin | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.40E-02 | 1 | O00141 | SGK | More | | Rosoxacin | hsa04962 | Vasopressin-regulated water reabsorption | 1.80E-02 | 2 | P62491, P46459 | RAB11A, NSF | More | | Rosoxacin | hsa04964 | Proximal tubule bicarbonate reclamation | 2.08E-04 | 3 | P22748, P00918, P49448 | CA4, CA2, GLUD2 | More | | Rosoxacin | hsa04966 | Collecting duct acid secretion | 2.17E-03 | 1 | P00918 | CA2 | More | | Rosoxacin | hsa04970 | Salivary secretion | 1.27E-04 | 8 | P07550, Q08828, P51828, P22694, Q14643, P17252, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, ITPR1, PRKCA, CALM1, CAMP | More | | Rosoxacin | hsa04971 | Gastric acid secretion | 9.27E-05 | 5 | Q08828, P51828, P15311, P0DP23, Q13557 | ADCY1, ADCY7, VIL2, CALM1, CAMK2D | More | | Rosoxacin | hsa04972 | Pancreatic secretion | 4.73E-02 | 2 | Q08828, P62491 | ADCY1, RAB11A | More | | Rosoxacin | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Rosoxacin | hsa04976 | Bile secretion | 1.59E-02 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | | Rosoxacin | hsa05010 | Alzheimer disease | 3.26E-05 | 18 | Q92542, O15239, O95298, P05496, P13073, P12074, Q00535, O75460, P0DP23, P01584, O95197, P18848, O15169, P67870, P31751, P05141, P45880, P28070 | NCSTN, NDUFA1, NDUFC2, ATP5G1, COX4I1, COX6A1, CDK5, ERN1, CALM1, IL1B, RTN3, ATF4, AXIN1, CSNK2B, AKT2, SLC25A5, VDAC2, PSMB4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q92542 | NCSTN | Nicastrin | 0.706 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.721 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.778 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.733 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.778 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.754 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.847 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 0.783 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 1 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.731 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.733 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.734 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P0DP23 | CALM1 | Calmodulin-1 | 0.762 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P01584 | IL1B | Interleukin-1 beta | 0.75 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P01584 | IL1B | Interleukin-1 beta | 0.762 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | O95197 | RTN3 | Reticulon-3 | 0.702 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | O15169 | AXIN1 | Axin-1 | 0.742 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P67870 | CSNK2B | Casein kinase II subunit beta | 0.709 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.726 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.779 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.708 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.778 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.736 |
| Rosoxacin | hsa05012 | Parkinson disease | 4.01E-02 | 6 | P21796, P60604, P19174, P0DP23, Q71U36, Q13509 | VDAC1, UBE2G2, PLCG1, CALM1, TUBA1A, TUBB3 | More | | Rosoxacin | hsa05016 | Huntington disease | 2.24E-02 | 7 | O95298, P24928, P30876, P62487, P05141, O75460, P28070 | NDUFC2, POLR2A, POLR2B, POLR2G, SLC25A5, ERN1, PSMB4 | More | | Rosoxacin | hsa05017 | Spinocerebellar ataxia | 1.71E-03 | 6 | O75460, Q8TB72, P31751, P28070, P05141, P21796 | ERN1, PUM2, AKT2, PSMB4, SLC25A5, VDAC1 | More | | Rosoxacin | hsa05020 | Prion disease | 1.81E-02 | 7 | P01584, P46531, P11142, P05496, P12074, P45880, Q99941 | IL1B, NOTCH1, HSPA8, ATP5G1, COX6A1, VDAC2, CREBL1 | More | | Rosoxacin | hsa05022 | Pathways of neurodegeneration - multiple diseases | 3.46E-03 | 11 | O95298, Q06055, Q8TEV9, O75460, P18848, P05141, Q00535, P01584, O15020, P0DP23, P28070 | NDUFC2, ATP5G2, SMCR8, ERN1, ATF4, SLC25A5, CDK5, IL1B, SPTBN2, CALM1, PSMB4 | More | | Rosoxacin | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Rosoxacin | hsa05031 | Amphetamine addiction | 6.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Rosoxacin | hsa05032 | Morphine addiction | 1.38E-05 | 7 | P62873, P63218, P50151, Q13370, P48169, P17252, P43250 | GNB1, GNG5, GNG10, PDE3B, GABRA4, PRKCA, GRK6 | More | | Rosoxacin | hsa05033 | Nicotine addiction | 2.43E-02 | 1 | P48169 | GABRA4 | More | | Rosoxacin | hsa05034 | Alcoholism | 9.92E-05 | 10 | Q13547, P0DP23, P62873, P63218, P50151, Q93077, P62807, Q93079, O60814, P68431 | HDAC1, CALM1, GNB1, GNG5, GNG10, HIST1H2AC, HIST1H2BC, H2BC9, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Rosoxacin | hsa05110 | Vibrio cholerae infection | 3.15E-02 | 3 | Q13488, P17252, P19174 | TCIRG1, PRKCA, PLCG1 | More | | Rosoxacin | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.00E-05 | 7 | Q16539, P09341, P19875, P19174, P25024, P25025, P07948 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Rosoxacin | hsa05131 | Shigellosis | 3.62E-03 | 18 | P01375, P25963, O00463, P14778, Q16539, Q04759, Q9UDY8, P61088, Q9NQL2, Q9H1Y0, P12814, Q14643, Q12778, P49841, Q13315, P10415, P21796, Q96A32 | TNF, NFKBIA, TRAF5, IL1R1, MAPK14, PRKCQ, MALT1, UBE2N, RRAGD, ATG5, ACTN1, ITPR1, FOXO1, GSK3B, ATM, BCL2, VDAC1, MYLPF | More | | Rosoxacin | hsa05132 | Salmonella infection | 2.98E-04 | 18 | P51617, P25963, P01375, P08238, Q9UJU2, P01106, P42338, Q13489, P10415, O75369, Q96A32, O60603, Q9BQS8, Q13561, Q71U36, Q13509, P68371, P49754 | IRAK1, NFKBIA, TNF, HSP90AB1, LEF1, MYC, PIK3CB, BIRC3, BCL2, FLNB, MYLPF, TLR2, FYCO1, DCTN2, TUBA1A, TUBB3, TUBB2C, VPS41 | More | | Rosoxacin | hsa05133 | Pertussis | 2.60E-04 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Rosoxacin | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Rosoxacin | hsa05140 | Leishmaniasis | 6.70E-05 | 11 | P13612, O75015, P14598, P13765, O60603, P25963, P01375, P49006, Q16539, P51617, Q15080 | ITGA4, FCGR3B, NCF1, HLA-DOB, TLR2, NFKBIA, TNF, MARCKSL1, MAPK14, IRAK1, NCF4 | More | | Rosoxacin | hsa05143 | African trypanosomiasis | 1.11E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Rosoxacin | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Rosoxacin | hsa05145 | Toxoplasmosis | 1.79E-04 | 14 | P51617, P25963, P01375, P10415, Q13489, P23458, P42224, P13765, P09917, Q8WYR1, Q13751, P0DMV8, P11142, O60603 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, JAK1, STAT1, HLA-DOB, ALOX5, PIK3R5, LAMB3, HSPA1A, HSPA8, TLR2 | More | | Rosoxacin | hsa05146 | Amoebiasis | 4.59E-11 | 12 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.859 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.771 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.927 | P08311 | CTSG | Cathepsin G | P09341 | CXCL1 | Growth-regulated alpha protein | 0.877 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.796 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.906 | P14780 | MMP9 | Matrix metalloproteinase-9 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.851 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.811 | Q13547 | HDAC1 | Histone deacetylase 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.837 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.813 | P08311 | CTSG | Cathepsin G | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.726 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | P11215 | ITGAM | Integrin alpha-M | -0.751 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P05089 | ARG1 | Arginase-1 | 0.89 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05089 | ARG1 | Arginase-1 | 0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | Q13547 | HDAC1 | Histone deacetylase 1 | P05089 | ARG1 | Arginase-1 | -0.769 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P05089 | ARG1 | Arginase-1 | -0.905 | P08311 | CTSG | Cathepsin G | P05089 | ARG1 | Arginase-1 | 0.931 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P05089 | ARG1 | Arginase-1 | -0.703 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.758 | P14780 | MMP9 | Matrix metalloproteinase-9 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.826 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.894 | P08311 | CTSG | Cathepsin G | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.847 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P12814 | ACTN1 | Alpha-actinin-1 | 0.788 | Q13547 | HDAC1 | Histone deacetylase 1 | P12814 | ACTN1 | Alpha-actinin-1 | -0.887 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P12814 | ACTN1 | Alpha-actinin-1 | -0.76 | P08311 | CTSG | Cathepsin G | P12814 | ACTN1 | Alpha-actinin-1 | 0.708 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P12814 | ACTN1 | Alpha-actinin-1 | -0.8 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P08311 | CTSG | Cathepsin G | 0.76 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08311 | CTSG | Cathepsin G | 0.79 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P08311 | CTSG | Cathepsin G | -0.898 | P08311 | CTSG | Cathepsin G | P08311 | CTSG | Cathepsin G | 1 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P08311 | CTSG | Cathepsin G | -0.733 |
| Rosoxacin | hsa05150 | Staphylococcus aureus infection | 9.05E-05 | 7 | P0C0L4, P13646, Q14532, P16109, P59665, P59666, P49913 | C4A, KRT13, KRT32, SELP, DEFA1; DEFA1B, DEFA3, CAMP | More | | Rosoxacin | hsa05152 | Tuberculosis | 4.02E-05 | 11 | Q13488, P0DP23, P48382, O60603, P01375, P10415, P13765, P01568, P49913, Q9UDY8, P51617 | TCIRG1, CALM1, RFX5, TLR2, TNF, BCL2, HLA-DOB, IFNA21, CAMP, MALT1, IRAK1 | More | | Rosoxacin | hsa05160 | Hepatitis C | 1.52E-03 | 7 | P60033, O00501, P29728, P49841, P01375, P48023, P01106 | CD81, CLDN5, OAS2, GSK3B, TNF, FASLG, MYC | More | | Rosoxacin | hsa05161 | Hepatitis B | 2.41E-03 | 11 | P17252, P14780, Q99941, P18848, P25963, P01375, P10415, P27348, P51617, O60603, Q14765 | PRKCA, MMP9, CREBL1, ATF4, NFKBIA, TNF, BCL2, YWHAQ, IRAK1, TLR2, STAT4 | More | | Rosoxacin | hsa05162 | Measles | 1.13E-03 | 9 | P01568, P25963, P23458, P42224, P14784, P07766, P42338, P0DMV8, P11142 | IFNA21, NFKBIA, JAK1, STAT1, IL2RB, CD3E, PIK3CB, HSPA1A, HSPA8 | More | | Rosoxacin | hsa05163 | Human cytomegalovirus infection | 1.14E-12 | 30 | P31751, P42338, P01375, P30511, P25963, P62873, P63218, P50151, Q14643, P0DP23, Q14344, Q8NHW4, Q08828, P51828, P22694, P23458, P49841, P01106, P14778, P01584, P61073, P17252, Q13651, P25025, Q16539, P18848, P04637, O00463, P30101, P01568 | AKT2, PIK3CB, TNF, HLA-F, NFKBIA, GNB1, GNG5, GNG10, ITPR1, CALM1, GNA13, CCL4L2, ADCY1, ADCY7, PRKACB, JAK1, GSK3B, MYC, IL1R1, IL1B, CXCR4, PRKCA, IL10RA, CXCR2, MAPK14, ATF4, TP53, TRAF5, PDIA3, IFNA21 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.726 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P01375 | TNF | Tumor necrosis factor | 0.732 | P27694 | RPA1 | Replication protein A 70 kDa DNA-binding subunit | P30511 | HLA-F | HLA class I histocompatibility antigen, alpha chain F | 0.898 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.737 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.763 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.728 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P0DP23 | CALM1 | Calmodulin-1 | 0.826 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P0DP23 | CALM1 | Calmodulin-1 | 0.762 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | P27694 | RPA1 | Replication protein A 70 kDa DNA-binding subunit | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | -0.727 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | -0.735 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.727 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.727 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.829 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.796 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.726 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.758 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.847 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.842 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.794 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 1 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01106 | MYC | Myc proto-oncogene protein | 0.719 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.778 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P01584 | IL1B | Interleukin-1 beta | 0.762 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.774 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.702 | P62942 | FKBP1A | Peptidyl-prolyl cis-trans isomerase FKBP1A | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.769 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.786 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.889 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.861 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.78 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.896 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.734 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.739 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.896 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 |
| Rosoxacin | hsa05164 | Influenza A | 4.49E-02 | 5 | P31751, P01584, P23458, P05141, Q9UBU9 | AKT2, IL1B, JAK1, SLC25A5, NXF1 | More | | Rosoxacin | hsa05166 | Human T-cell leukemia virus 1 infection | 3.90E-02 | 7 | P23458, P05141, P62826, Q08828, P51828, P18848, P31751 | JAK1, SLC25A5, RAN, ADCY1, ADCY7, ATF4, AKT2 | More | | Rosoxacin | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 9.52E-08 | 16 | P01568, P42224, P25963, P42338, P40189, P62873, P62879, P63218, P50151, P19174, P16298, Q02750, P07948, P01106, P0DP23, P0CG47 | IFNA21, STAT1, NFKBIA, PIK3CB, IL6ST, GNB1, GNB2, GNG5, GNG10, PLCG1, PPP3CB, MAP2K1, LYN, MYC, CALM1, UBB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.841 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.748 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | P11511 | CYP19A1 | Aromatase | P62879 | GNB2 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 | 0.704 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | P11511 | CYP19A1 | Aromatase | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.706 | P11511 | CYP19A1 | Aromatase | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.783 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.852 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01106 | MYC | Myc proto-oncogene protein | 0.719 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P0DP23 | CALM1 | Calmodulin-1 | 0.826 | P11511 | CYP19A1 | Aromatase | P0CG47 | UBB | Polyubiquitin-B | -0.741 |
| Rosoxacin | hsa05168 | Herpes simplex virus 1 infection | 9.55E-06 | 17 | P25963, P01568, P42224, Q07955, Q01130, Q13243, Q13489, P30101, P42338, Q9Y2A4, Q13398, P51522, P17038, Q03923, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, PDIA3, PIK3CB, ZNF443, ZNF211, ZNF83, ZNF43, ZNF85, ZNF140, ZNF189, ZNF212 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.825 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.841 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.935 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.866 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.725 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.703 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.882 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.835 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.862 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.781 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.886 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.908 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.732 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.747 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.739 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.896 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Q9Y2A4 | ZNF443 | Zinc finger protein 443 | 0.731 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13398 | ZNF211 | Zinc finger protein 211 | 0.956 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13398 | ZNF211 | Zinc finger protein 211 | 0.891 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q13398 | ZNF211 | Zinc finger protein 211 | 0.763 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P51522 | ZNF83 | Zinc finger protein 83 | 0.851 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P17038 | ZNF43 | Zinc finger protein 43 | 0.718 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q03923 | ZNF85 | Zinc finger protein 85 | -0.731 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q03923 | ZNF85 | Zinc finger protein 85 | -0.73 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P52738 | ZNF140 | Zinc finger protein 140 | 0.71 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O75820 | ZNF189 | Zinc finger protein 189 | -0.756 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O75820 | ZNF189 | Zinc finger protein 189 | -0.749 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | O75820 | ZNF189 | Zinc finger protein 189 | 0.768 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q9UDV6 | ZNF212 | Zinc finger protein 212 | 0.798 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q9UDV6 | ZNF212 | Zinc finger protein 212 | 0.776 |
| Rosoxacin | hsa05169 | Epstein-Barr virus infection | 1.66E-04 | 19 | P13765, P01106, Q13547, O00463, P25963, Q16539, P42338, P07948, P30101, Q13761, P24522, O75293, P42224, P01568, P01375, P29728, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, TRAF5, NFKBIA, MAPK14, PIK3CB, LYN, PDIA3, RUNX3, GADD45A, GADD45B, STAT1, IFNA21, TNF, OAS2, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.748 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01106 | MYC | Myc proto-oncogene protein | 0.719 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.795 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13547 | HDAC1 | Histone deacetylase 1 | 0.701 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.896 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.849 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.713 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.852 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.896 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.769 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.804 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.805 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.847 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P29728 | OAS2 | 2'-5'-oligoadenylate synthase 2 | -0.72 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.782 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.839 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.862 |
| Rosoxacin | hsa05170 | Human immunodeficiency virus 1 infection | 2.29E-10 | 28 | P42338, Q02750, P62873, P62879, P63218, P50151, P16298, P0DP23, P01375, Q05397, P17252, O00463, P30101, Q14643, P01568, P51617, P25963, O60603, Q13315, O95067, P19174, P23528, P07766, P10415, Q13619, Q93034, Q9Y6Q5, P20333 | PIK3CB, MAP2K1, GNB1, GNB2, GNG5, GNG10, PPP3CB, CALM1, TNF, PTK2, PRKCA, TRAF5, PDIA3, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, ATM, CCNB2, PLCG1, CFL1, CD3E, BCL2, CUL4A, CUL5, AP1M2, TNFRSF1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P11511 | CYP19A1 | Aromatase | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.783 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.777 | P11511 | CYP19A1 | Aromatase | P62879 | GNB2 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 | 0.704 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | P11511 | CYP19A1 | Aromatase | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.706 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P0DP23 | CALM1 | Calmodulin-1 | 0.826 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P0DP23 | CALM1 | Calmodulin-1 | -0.772 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P11511 | CYP19A1 | Aromatase | Q05397 | PTK2 | Focal adhesion kinase 1 | 0.75 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | P08246 | ELA2 | Neutrophil elastase | P17252 | PRKCA | Protein kinase C alpha type | -0.735 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P17252 | PRKCA | Protein kinase C alpha type | 0.844 | P08246 | ELA2 | Neutrophil elastase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.814 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.773 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.739 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.896 | P08246 | ELA2 | Neutrophil elastase | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.816 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.858 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P01568 | IFNA21 | Interferon alpha-21 | 0.721 | P08246 | ELA2 | Neutrophil elastase | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.734 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.807 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | P08246 | ELA2 | Neutrophil elastase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.701 | P08246 | ELA2 | Neutrophil elastase | O60603 | TLR2 | Toll-like receptor 2 | 0.853 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O60603 | TLR2 | Toll-like receptor 2 | -0.884 | P08246 | ELA2 | Neutrophil elastase | Q13315 | ATM | Serine-protein kinase ATM | -0.742 | P08246 | ELA2 | Neutrophil elastase | O95067 | CCNB2 | G2/mitotic-specific cyclin-B2 | 0.711 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P23528 | CFL1 | Cofilin-1 | -0.853 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P23528 | CFL1 | Cofilin-1 | 0.741 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.839 | P08246 | ELA2 | Neutrophil elastase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.942 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 1 | P08246 | ELA2 | Neutrophil elastase | Q13619 | CUL4A | Cullin-4A | -0.707 | P08246 | ELA2 | Neutrophil elastase | Q93034 | CUL5 | Cullin-5 | -0.744 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q93034 | CUL5 | Cullin-5 | 0.704 | P08246 | ELA2 | Neutrophil elastase | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | 0.811 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.901 | P11511 | CYP19A1 | Aromatase | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | -0.75 |
| Rosoxacin | hsa05171 | Coronavirus disease - COVID-19 | 4.35E-03 | 14 | P01584, P25963, P42224, P01568, P62753, P36578, P62888, P61927, P61513, P62829, P40189, P42338, P19174, P17252 | IL1B, NFKBIA, STAT1, IFNA21, RPS6, RPL4, RPL30, RPL37, RPL37A, RPL23, IL6ST, PIK3CB, PLCG1, PRKCA | More | | Rosoxacin | hsa05200 | Pathways in cancer | 1.02E-09 | 32 | Q13751, P42338, P08238, P42224, P25963, P19174, P01106, P17252, P43246, P84022, Q13485, P52701, Q13547, P10826, P14923, P30279, P30281, Q13489, P49767, P14921, P43657, P62873, P63218, P50151, Q14344, Q7LDG7, P78417, O75293, P0DP23, P01568, P14784, P40189 | LAMB3, PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, MYC, PRKCA, MSH2, SMAD3, SMAD4, MSH6, HDAC1, RARB, JUP, CCND2, CCND3, BIRC3, VEGFC, ETS1, P2RY5, GNB1, GNG5, GNG10, GNA13, RASGRP2, GSTO1, GADD45B, CALM1, IFNA21, IL2RB, IL6ST | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.705 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.802 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.926 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.841 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01106 | MYC | Myc proto-oncogene protein | 0.719 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.925 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.887 | P29375 | JARID1A | Lysine-specific demethylase 5A | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.794 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P52701 | MSH6 | DNA mismatch repair protein Msh6 | 0.91 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13547 | HDAC1 | Histone deacetylase 1 | 0.701 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P10826 | RARB | Retinoic acid receptor beta | 0.779 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14923 | JUP | Junction plakoglobin | -0.716 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14923 | JUP | Junction plakoglobin | -0.735 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P30279 | CCND2 | G1/S-specific cyclin-D2 | 0.704 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.747 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.871 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P49767 | VEGFC | Vascular endothelial growth factor C | -0.778 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14921 | ETS1 | Protein C-ets-1 | 0.731 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.707 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | -0.735 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.703 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.849 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.919 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.847 | P29375 | JARID1A | Lysine-specific demethylase 5A | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P0DP23 | CALM1 | Calmodulin-1 | 0.826 | P29375 | JARID1A | Lysine-specific demethylase 5A | P0DP23 | CALM1 | Calmodulin-1 | 0.755 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.865 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.912 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.748 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 |
| Rosoxacin | hsa05202 | Transcriptional misregulation in cancer | 9.81E-12 | 21 | Q12778, Q15532, Q13315, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P08069, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, P12980, P24522 | FOXO1, SS18, ATM, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, IGF1R, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08246 | ELA2 | Neutrophil elastase | Q12778 | FOXO1 | Forkhead box protein O1 | -0.75 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.794 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.795 | P08246 | ELA2 | Neutrophil elastase | Q15532 | SS18 | Protein SSXT | -0.806 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q15532 | SS18 | Protein SSXT | 0.877 | P04183 | TK1 | Thymidine kinase, cytosolic | Q13315 | ATM | Serine-protein kinase ATM | -0.765 | P08246 | ELA2 | Neutrophil elastase | Q13315 | ATM | Serine-protein kinase ATM | -0.742 | P08311 | CTSG | Cathepsin G | Q13315 | ATM | Serine-protein kinase ATM | -0.709 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P14780 | MMP9 | Matrix metalloproteinase-9 | P14780 | MMP9 | Matrix metalloproteinase-9 | 1 | P08246 | ELA2 | Neutrophil elastase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.859 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.869 | P08311 | CTSG | Cathepsin G | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.79 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.765 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.746 | P14780 | MMP9 | Matrix metalloproteinase-9 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.851 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.813 | P08311 | CTSG | Cathepsin G | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.726 | P04183 | TK1 | Thymidine kinase, cytosolic | P14923 | JUP | Junction plakoglobin | -0.774 | P08246 | ELA2 | Neutrophil elastase | P14923 | JUP | Junction plakoglobin | -0.811 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14923 | JUP | Junction plakoglobin | 0.861 | P04183 | TK1 | Thymidine kinase, cytosolic | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.781 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.7 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.844 | P08311 | CTSG | Cathepsin G | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.909 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.921 | P08246 | ELA2 | Neutrophil elastase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.766 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.762 | P08311 | CTSG | Cathepsin G | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.79 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.746 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | P08246 | ELA2 | Neutrophil elastase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.716 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.848 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.758 | P08246 | ELA2 | Neutrophil elastase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.725 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.816 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O15550 | UTX | Lysine-specific demethylase 6A | -0.778 | P08069 | IGF1R | Insulin-like growth factor 1 receptor | P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | P08246 | ELA2 | Neutrophil elastase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.824 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | P08246 | ELA2 | Neutrophil elastase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.824 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | P04183 | TK1 | Thymidine kinase, cytosolic | P05164 | MPO | Myeloperoxidase | 0.917 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | P08246 | ELA2 | Neutrophil elastase | P05164 | MPO | Myeloperoxidase | 0.903 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P05164 | MPO | Myeloperoxidase | -0.867 | P08311 | CTSG | Cathepsin G | P05164 | MPO | Myeloperoxidase | 0.956 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P05164 | MPO | Myeloperoxidase | -0.81 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P05164 | MPO | Myeloperoxidase | -0.866 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.858 | P08246 | ELA2 | Neutrophil elastase | P12838 | DEFA4 | Neutrophil defensin 4 | 0.709 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P12838 | DEFA4 | Neutrophil defensin 4 | -0.852 | P08311 | CTSG | Cathepsin G | P12838 | DEFA4 | Neutrophil defensin 4 | 0.817 | P04183 | TK1 | Thymidine kinase, cytosolic | P08246 | ELA2 | Neutrophil elastase | 0.838 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | P08246 | ELA2 | Neutrophil elastase | P08246 | ELA2 | Neutrophil elastase | 1 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P08246 | ELA2 | Neutrophil elastase | -0.742 | P08311 | CTSG | Cathepsin G | P08246 | ELA2 | Neutrophil elastase | 0.792 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P08246 | ELA2 | Neutrophil elastase | -0.942 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08246 | ELA2 | Neutrophil elastase | -0.76 | P04183 | TK1 | Thymidine kinase, cytosolic | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.783 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.752 | P08246 | ELA2 | Neutrophil elastase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.75 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.822 | P08311 | CTSG | Cathepsin G | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.853 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.766 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.879 | P14780 | MMP9 | Matrix metalloproteinase-9 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.812 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13547 | HDAC1 | Histone deacetylase 1 | 0.83 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12980 | LYL1 | Protein lyl-1 | 0.716 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P12980 | LYL1 | Protein lyl-1 | -0.73 | P04183 | TK1 | Thymidine kinase, cytosolic | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.718 | P14780 | MMP9 | Matrix metalloproteinase-9 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.765 | P08246 | ELA2 | Neutrophil elastase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.7 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.787 | P08311 | CTSG | Cathepsin G | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.799 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 |
| Rosoxacin | hsa05203 | Viral carcinogenesis | 2.99E-06 | 17 | Q12933, Q99941, P18848, P42229, P42338, P06746, P07948, P27348, P29083, Q13547, Q15283, P12814, P25963, P61978, P62807, Q93079, O60814 | TRAF2, CREBL1, ATF4, STAT5A, PIK3CB, POLB, LYN, YWHAQ, GTF2E1, HDAC1, RASA2, ACTN1, NFKBIA, HNRPK, HIST1H2BC, H2BC9, H2BC12 | More | | Rosoxacin | hsa05204 | Chemical carcinogenesis | 1.77E-04 | 4 | Q16772, P09211, P78417, P11712 | GSTA3, GSTP1, GSTO1, CYP2C9 | More | | Rosoxacin | hsa05205 | Proteoglycans in cancer | 4.93E-03 | 11 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P08069, P04628, Q13635, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, IGF1R, WNT1, PTCH1, CD63 | More | | Rosoxacin | hsa05206 | MicroRNAs in cancer | 4.00E-04 | 13 | P30304, P09493, P15311, P21860, P01106, P42338, P61978, P46531, Q13547, P63279, P22105, P20827, P19174 | CDC25A, TPM1, VIL2, ERBB3, MYC, PIK3CB, HNRPK, NOTCH1, HDAC1, UBE2I, TNXB, EFNA1, PLCG1 | More | | Rosoxacin | hsa05210 | Colorectal cancer | 4.94E-02 | 2 | Q13485, P52701 | SMAD4, MSH6 | More | | Rosoxacin | hsa05212 | Pancreatic cancer | 1.45E-04 | 8 | P42338, P31751, Q15311, P23458, P42224, P84022, Q13485, O75293 | PIK3CB, AKT2, RALBP1, JAK1, STAT1, SMAD3, SMAD4, GADD45B | More | | Rosoxacin | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Rosoxacin | hsa05214 | Glioma | 8.26E-07 | 6 | P08069, P0DP23, P17252, P42338, P19174, O75293 | IGF1R, CALM1, PRKCA, PIK3CB, PLCG1, GADD45B | More | | Rosoxacin | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P08069 | IGF1R | More | | Rosoxacin | hsa05218 | Melanoma | 2.77E-03 | 4 | P08069, Q9NRA1, P42338, O75293 | IGF1R, PDGFC, PIK3CB, GADD45B | More | | Rosoxacin | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Rosoxacin | hsa05220 | Chronic myeloid leukemia | 1.15E-03 | 7 | Q13547, P01106, Q13485, P25963, P84022, P42338, O75293 | HDAC1, MYC, SMAD4, NFKBIA, SMAD3, PIK3CB, GADD45B | More | | Rosoxacin | hsa05221 | Acute myeloid leukemia | 3.29E-02 | 3 | P14923, Q15744, P05164 | JUP, CEBPE, MPO | More | | Rosoxacin | hsa05222 | Small cell lung cancer | 9.25E-04 | 10 | P10826, P42338, Q13751, Q13489, P10415, P25963, Q13077, O00463, P24522, O75293 | RARB, PIK3CB, LAMB3, BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A, GADD45B | More | | Rosoxacin | hsa05223 | Non-small cell lung cancer | 5.61E-04 | 6 | P17252, P42338, P19174, P10826, Q9HC35, O75293 | PRKCA, PIK3CB, PLCG1, RARB, EML4, GADD45B | More | | Rosoxacin | hsa05224 | Breast cancer | 1.24E-02 | 5 | P08069, P49841, Q92837, P04637, P24522 | IGF1R, GSK3B, FRAT1, TP53, GADD45A | More | | Rosoxacin | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P08069 | IGF1R | More | | Rosoxacin | hsa05226 | Gastric cancer | 3.79E-02 | 2 | Q02750, O15169 | MAP2K1, AXIN1 | More | | Rosoxacin | hsa05231 | Choline metabolism in cancer | 5.22E-07 | 10 | P31751, P42338, Q9NRA1, Q9Y259, P19174, P23743, P49619, Q16760, O14986, P17252 | AKT2, PIK3CB, PDGFC, CHKB, PLCG1, DGKA, DGKG, DGKD, PIP5K1B, PRKCA | More | | Rosoxacin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 6.89E-11 | 15 | P25963, P42338, O95267, P19174, P07766, P20963, P09693, P06239, P42224, O60603, P10747, Q04759, Q16539, Q9HC35, P01730 | NFKBIA, PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, STAT1, TLR2, CD28, PRKCQ, MAPK14, EML4, CD4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.824 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.716 | P08311 | CTSG | Cathepsin G | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.705 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.737 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.762 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.782 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.839 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.797 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.744 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.812 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.809 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.767 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.771 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.75 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.807 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.734 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P30304 | CDC25A | M-phase inducer phosphatase 1 | Q9HC35 | EML4 | Echinoderm microtubule-associated protein-like 4 | 0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.707 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.708 |
| Rosoxacin | hsa05310 | Asthma | 9.09E-08 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Rosoxacin | hsa05320 | Autoimmune thyroid disease | 8.64E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Rosoxacin | hsa05321 | Inflammatory bowel disease | 6.29E-12 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | P08246 | ELA2 | Neutrophil elastase | O60603 | TLR2 | Toll-like receptor 2 | 0.853 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.748 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | P08246 | ELA2 | Neutrophil elastase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.729 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.756 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.861 | P08246 | ELA2 | Neutrophil elastase | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.783 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.821 | P08311 | CTSG | Cathepsin G | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.81 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.927 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.808 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.858 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.765 | P14780 | MMP9 | Matrix metalloproteinase-9 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.747 | P08246 | ELA2 | Neutrophil elastase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.724 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.878 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P08311 | CTSG | Cathepsin G | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.763 |
| Rosoxacin | hsa05322 | Systemic lupus erythematosus | 2.03E-07 | 15 | O75015, P08246, P08311, P09871, P01375, P10747, P13765, Q6FI13, Q93077, P62807, Q16778, O60814, P68431, P12814, P05455 | FCGR3B, ELA2, CTSG, C1S, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, ACTN1, SSB | More | | Rosoxacin | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Rosoxacin | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Rosoxacin | hsa05332 | Graft-versus-host disease | 1.03E-10 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.748 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | P08246 | ELA2 | Neutrophil elastase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.729 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.734 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P14416 | DRD2 | D(2) dopamine receptor | P48023 | FASLG | Tumor necrosis factor ligand superfamily member 6 | 0.7 | P08246 | ELA2 | Neutrophil elastase | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | -0.854 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P01375 | TNF | Tumor necrosis factor | -0.783 | P14416 | DRD2 | D(2) dopamine receptor | P01375 | TNF | Tumor necrosis factor | -0.767 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | P01375 | TNF | Tumor necrosis factor | -0.709 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.846 | P14780 | MMP9 | Matrix metalloproteinase-9 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.867 | P08246 | ELA2 | Neutrophil elastase | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.775 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.915 | P08311 | CTSG | Cathepsin G | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.867 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.737 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.846 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.837 | P08246 | ELA2 | Neutrophil elastase | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.7 | Q92630 | DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.941 | P08311 | CTSG | Cathepsin G | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.812 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.726 |
| Rosoxacin | hsa05340 | Primary immunodeficiency | 4.24E-02 | 3 | P01730, P07766, P06239 | CD4, CD3E, LCK | More | | Rosoxacin | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 2.17E-03 | 1 | P54284 | CACNB3 | More | | Rosoxacin | hsa05414 | Dilated cardiomyopathy | 2.60E-03 | 3 | P54284, P09493, P26678 | CACNB3, TPM1, PLN | More | | Rosoxacin | hsa05418 | Fluid shear stress and atherosclerosis | 1.56E-05 | 12 | Q16539, P42338, Q14145, P14598, P10599, P14780, P01375, P04637, P14778, P27930, P0DP23, P08238 | MAPK14, PIK3CB, KEAP1, NCF1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2, CALM1, HSP90AB1 | More | | |